Jacques Moisan

942 total citations
31 papers, 618 citations indexed

About

Jacques Moisan is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jacques Moisan has authored 31 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jacques Moisan's work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jacques Moisan is often cited by papers focused on CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jacques Moisan collaborates with scholars based in United States, Canada and Germany. Jacques Moisan's co-authors include I‐Cheng Ho, Roland Grenningloh, Estelle Bettelli, Mohamed Oukka, Danuta Radzioch, Pierre Camateros, Marie‐Christine Guiot, James G. Martin, Thusanth Thuraisingam and Muhannad Hassan and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jacques Moisan

31 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Moisan United States	11	360	171	130	122	64	31	618
Gabrielle Carvalho France	11	190 0.5×	148 0.9×	77 0.6×	206 1.7×	59 0.9×	13	511
Alexander Gregorieff Canada	6	214 0.6×	89 0.5×	99 0.8×	305 2.5×	179 2.8×	6	602
Jonathan Hacha Belgium	8	134 0.4×	186 1.1×	53 0.4×	96 0.8×	113 1.8×	8	417
Makoto Kurose Japan	12	98 0.3×	103 0.6×	59 0.5×	193 1.6×	109 1.7×	44	579
Li-Hong Ben United States	8	423 1.2×	73 0.4×	79 0.6×	115 0.9×	21 0.3×	9	584
Zhong-Jian Shen United States	18	249 0.7×	103 0.6×	188 1.4×	584 4.8×	38 0.6×	21	803
Francesca Mion Italy	11	449 1.2×	143 0.8×	68 0.5×	136 1.1×	31 0.5×	16	611
Cheryl A. Hatfield United States	13	223 0.6×	179 1.0×	50 0.4×	65 0.5×	62 1.0×	15	456
Murielle Corvaisier France	9	732 2.0×	45 0.3×	330 2.5×	126 1.0×	31 0.5×	9	929
Wook‐Jin Chae United States	7	239 0.7×	51 0.3×	76 0.6×	265 2.2×	35 0.5×	10	565

Countries citing papers authored by Jacques Moisan

Since Specialization

Citations

This map shows the geographic impact of Jacques Moisan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Moisan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Moisan more than expected).

Fields of papers citing papers by Jacques Moisan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Moisan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Moisan. The network helps show where Jacques Moisan may publish in the future.

Co-authorship network of co-authors of Jacques Moisan

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Moisan. A scholar is included among the top collaborators of Jacques Moisan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Moisan. Jacques Moisan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schiemann, Kai, Kalyan C. Nallaparaju, Carsten Boesler, et al.. (2024). Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo. Molecular Cancer Therapeutics. 23(11). 1517–1529. 6 indexed citations

Vantourout, Pierre, Thomas S. Hayday, Adam Laing, et al.. (2023). Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials. Science Advances. 9(49). eadj6174–eadj6174. 3 indexed citations

Donahue, Renee N., Madan Katragadda, Wei Huang, et al.. (2023). A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity. Science Translational Medicine. 15(724). eadi0258–eadi0258. 10 indexed citations

Sullivan, Ryan J., Ke Liu, Jason M. Redman, et al.. (2023). Trial START-001: A phase 1/2 study of STAR0602, a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors post checkpoint inhibitor (CPI) treatment.. Journal of Clinical Oncology. 41(16_suppl). TPS2671–TPS2671. 1 indexed citations

Su, Zhen, Jonathan C. Hsu, Jacques Moisan, et al.. (2022). 1316 A novel class of T cell-activating antibody that selectively targets the TCR b chain to promote antitumor activity through activation and expansion of a novel, polyclonal effector memory T cell subset. Regular and Young Investigator Award Abstracts. A1367–A1367. 1 indexed citations

Xu, Chunxiao, Sireesha Yalavarthi, Clotilde Bourin, et al.. (2022). 497 Evaluation of the TIGIT+ immune subset depletion effect of the anti-TIGIT antibody M6223. Regular and Young Investigator Award Abstracts. A518–A518. 1 indexed citations

Xu, Chunxiao, Sireesha Yalavarthi, Clotilde Bourin, et al.. (2022). Abstract 593: Anti-tumor immunity and efficacy of combination treatment of M6223 and bintrafusp alfa versus the combination of M6223 and anti-PD-L1 in preclinical tumor models. Cancer Research. 82(12_Supplement). 593–593. 1 indexed citations

Xu, Chunxiao, Feng Jiang, Lindsay Webb, et al.. (2021). 326 The anti-TIGIT antibody M6223 induces significant anti-tumor efficacy and immune response via multiple mechanisms of action. Regular and Young Investigator Award Abstracts. A351–A352. 1 indexed citations

Hu, Xiao, Kinga Majchrzak, Xikui Liu, et al.. (2018). In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Research. 78(14). 3888–3898. 42 indexed citations

10.

Zhong, Haihong, April Davis, Maria Ouzounova, et al.. (2016). A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Research. 76(2). 480–490. 40 indexed citations

11.

Grenningloh, Roland, Shi‐Chuen Miaw, Jacques Moisan, Barbara J. Graves, & I‐Cheng Ho. (2008). Role of Ets‐1 phosphorylation in the effector function of Th cells. European Journal of Immunology. 38(6). 1700–1705. 16 indexed citations

12.

Moisan, Jacques, Roland Grenningloh, Estelle Bettelli, Mohamed Oukka, & I‐Cheng Ho. (2007). Ets-1 is a negative regulator of Th17 differentiation (35.34). The Journal of Immunology. 178(1_Supplement). S8–S8. 5 indexed citations

13.

Camateros, Pierre, Meiyo Tamaoka, Muhannad Hassan, et al.. (2007). Chronic Asthma–induced Airway Remodeling Is Prevented by Toll-like Receptor-7/8 Ligand S28463. American Journal of Respiratory and Critical Care Medicine. 175(12). 1241–1249. 110 indexed citations

14.

Thuraisingam, Thusanth, Yong Xu, Jacques Moisan, et al.. (2007). Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands. Molecular Immunology. 44(14). 3482–3491. 21 indexed citations

15.

Moisan, Jacques, Roland Grenningloh, Estelle Bettelli, Mohamed Oukka, & I‐Cheng Ho. (2007). Ets-1 is a negative regulator of Th17 differentiation. The Journal of Experimental Medicine. 204(12). 2825–2835. 174 indexed citations

16.

Thuraisingam, Thusanth, et al.. (2006). Delayed Cutaneous Wound Healing in Mice Lacking Solute Carrier 11a1 (Formerly Nramp1): Correlation with Decreased Expression of Secretory Leukocyte Protease Inhibitor. Journal of Investigative Dermatology. 126(4). 890–901. 21 indexed citations

17.

Moisan, Jacques, Thusanth Thuraisingam, Jill Hénault, Juan Bautista De Sanctis, & Danuta Radzioch. (2006). Role of SLC11A1 (formerly NRAMP1) in regulation of signal transduction induced by Toll-like receptor 7 ligands. FEMS Immunology & Medical Microbiology. 47(1). 138–147. 10 indexed citations

18.

Camateros, Pierre, Jacques Moisan, Jill Hénault, et al.. (2006). Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma. Current Pharmaceutical Design. 12(19). 2365–2374. 8 indexed citations

19.

Moisan, Jacques, Pierre Camateros, Thusanth Thuraisingam, et al.. (2005). TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. American Journal of Physiology-Lung Cellular and Molecular Physiology. 290(5). L987–L995. 80 indexed citations

20.

Moisan, Jacques, Wojciech Wojciechowski, Claudine Guilbault, et al.. (2001). Clearance of Infection withMycobacterium bovisBCG in Mice Is Enhanced by Treatment with S28463 (R-848), and Its Efficiency Depends on Expression of Wild-TypeNramp1(Resistance Allele). Antimicrobial Agents and Chemotherapy. 45(11). 3059–3064. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact